Zhou X P, Smith W M, Gimm O, Mueller E, Gao X, Sarraf P, Prior T W, Plass C, von Deimling A, Black P M, Yates A J, Eng C
Clinical Cancer Genetics Program, Ohio State University, 420 W 12th Avenue, Room 690C MRF, Columbus, OH 43210, USA.
J Med Genet. 2000 Jun;37(6):410-4. doi: 10.1136/jmg.37.6.410.
PPARgamma, the gamma isoform of a family of peroxisome proliferator activated receptors, plays a key role in adipocyte differentiation. Recently, its broad expression in multiple tissues and several epithelial cancers has been shown. Further, somatic loss of function mutations in PPARgamma have been found in primary colorectal carcinomas. We sought to determine if somatic high penetrance mutations in this gene might also play a role in glioblastoma multiforme (GBM). We also examined this gene to determine if common low penetrance polymorphic alleles might lend low level susceptibility to GBM in the general population. No somatic high penetrance mutations were detected in 96 sporadic GBMs. However, polymorphic alleles at codons 12 and 449 were significantly over-represented among the 27 unrelated American patients with sporadic GBM compared to 80 race matched controls. While nine (33%) were heterozygous for the P12A variant, c.34C/G (cytosine to guanine change at nucleotide 34), 12 (15%) controls were heterozygous for P12A (p<0.05). Similarly, 13 of 26 (50%) glioblastoma patients compared to 10 of 80 (12%) normal controls were found to have the heterozygous H449H polymorphism (p<0.001). The over-representation of H449H in glioblastoma patients was confirmed with a second validation set of American patients. When both American series were combined, polymorphic H449H was over-represented among cases versus controls (p<0.001) and there was a similar trend (p=0.07) for P12A. The precise mechanism for this association is unknown but these PPARgamma polymorphisms may be acting in a low penetrance predisposing manner. However, these associations were not found in a German population, possibly arguing that if these variants are in linkage disequilibrium with a third locus, then this effect is relatively new, after the settlement of the American colonies.
过氧化物酶体增殖物激活受体(PPAR)家族的γ亚型PPARγ在脂肪细胞分化中起关键作用。最近,已证明其在多种组织和几种上皮癌中广泛表达。此外,在原发性结直肠癌中发现了PPARγ的体细胞功能丧失突变。我们试图确定该基因中的体细胞高穿透性突变是否也可能在多形性胶质母细胞瘤(GBM)中起作用。我们还研究了该基因,以确定常见的低穿透性多态性等位基因是否可能使普通人群对GBM具有低水平易感性。在96例散发性GBM中未检测到体细胞高穿透性突变。然而,与80名种族匹配的对照相比,在27名不相关的美国散发性GBM患者中,第12位密码子和第449位密码子的多态性等位基因明显过度表达。虽然9名(33%)患者为P12A变体(c.34C/G,核苷酸34处胞嘧啶到鸟嘌呤的变化)杂合子,但12名(15%)对照为P12A杂合子(p<0.05)。同样,26例胶质母细胞瘤患者中有13例(50%)与80例正常对照中的10例(12%)相比,被发现具有杂合子H449H多态性(p<0.001)。在美国患者的第二个验证组中证实了胶质母细胞瘤患者中H449H的过度表达。当两个美国系列合并时,多态性H449H在病例组与对照组中过度表达(p<0.001),P12A也有类似趋势(p=0.07)。这种关联的确切机制尚不清楚,但这些PPARγ多态性可能以低穿透性易感性方式起作用。然而,在德国人群中未发现这些关联,这可能表明如果这些变体与第三个基因座处于连锁不平衡状态,那么这种效应相对较新,是在美国殖民地定居之后出现的。